Calling All Young Scientists

15 new PhD positions are being advertised for a Marie Curie Innovative Training Network project running from Jan 2017 until end of 2021. Students will work in a highly collaborative environment and be trained within in3, acquiring a unique multidisciplinary skill set that it is hoped will give them a competitive employment advantage in safety assessment sciences: either in industry, governmental bodies or academia.  Recruitment is open now and will remain open until all positions are filled. Each of the 15 positions advertised is a 3 year PhD position. Applicants must be Early-Stage Researchers (ESRs), meaning that they are within the first four years (full-time equivalent) of their research careers and have not yet been awarded a doctoral degree (PhD). It is expected that the first candidates will commence employment in March 2017 and the aim is to have all positions filled by July 2017. For more information and to apply for a position you should visit http://estiv.org/in3.

The in3 project is a Marie Curie Innovative Training Network that aims to drive the synergistic development and utilisation of in vitro and in silico tools for human chemical and nanomaterial (NM) safety assessment. The project will focus on differentiation of human induced pluripotent stem cells (hiPSC) to toxicologically relevant target tissues including; brain, lung, liver and kidney. Tissues, from the same genetic backgrounds, will be exposed to several compounds and the data generated will be used to develop safety assessment approaches by integrating cheminformatics, mechanistic toxicology and biokinetics into computational models.

The initiative includes 17 benificiary and partner organisations including Evercyte GmbH of Austria, an established organisation focused on providing relevant human cell lines as model systems for cell based assays, production host and cellular therapy applications.
 

ACE 17 Purecontrol FG